Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, Netherlands
Neurology, Erasmus MC University Medical Center, Rotterdam, Netherlands.
J Neurointerv Surg. 2022 Jul;14(7):660-665. doi: 10.1136/neurintsurg-2021-017726. Epub 2021 Jul 15.
Approximately one-third of patients with ischemic stroke treated with endovascular treatment do not recover to functional independence despite rapid and successful recanalization. We aimed to quantify the importance of predictors of poor functional outcome despite successful reperfusion.
We analyzed patients from the MR CLEAN Registry between March 2014 and November 2017 with successful reperfusion (extended Thrombolysis In Cerebral Infarction ≥2B). First, predictors were selected based on expert opinion and were clustered according to acquisition over time (ie, baseline patient factors, imaging factors, treatment factors, and postprocedural factors). Second, several models were constructed to predict 90-day functional outcome (modified Rankin Scale (mRS)). The relative importance of individual predictors in the most extensive model was expressed by the proportion of unique added χ to the model of that individual predictor.
Of 3180 patients, 1913 (60%) had successful reperfusion. Of these 1913 patients, 1046 (55%) were functionally dependent at 90 days (mRS >2). The most important predictors for mRS were baseline patient factors (ie, pre-stroke mRS, added χ 0.16; National Institutes of Health Stroke Scale score at baseline, added χ 0.12; age, added χ 0.10), and postprocedural factors (ie, symptomatic intracranial hemorrhage (sICH), added χ 0.12; pneumonia, added χ 0.09). The probability of functional independence for a typical stroke patient with sICH was 54% (95% CI 36% to 72%) lower compared with no sICH, and 21% (95% CI 4% to 38%) for pneumonia compared with no pneumonia.
Baseline patient factors and postprocedural adverse events are important predictors of poor functional outcome in successfully reperfused patients with ischemic stroke. This implies that prevention of postprocedural adverse events has the greatest potential to further improve outcomes in these patients.
接受血管内治疗的缺血性卒中患者中,约有三分之一尽管血管再通迅速且成功,但仍无法恢复到功能独立性。我们旨在量化尽管再通成功但预后不良的预测因素的重要性。
我们分析了 2014 年 3 月至 2017 年 11 月 MR CLEAN 登记处中接受成功再通(扩展血栓溶解治疗脑梗死 ≥2B)的患者。首先,根据专家意见选择预测因素,并根据随时间采集的因素进行聚类(即基线患者因素、影像学因素、治疗因素和术后因素)。其次,构建了几个模型来预测 90 天的功能结局(改良 Rankin 量表(mRS))。个体预测因素在最广泛模型中的相对重要性,通过该个体预测因素对模型的独特增加 χ 表示。
在 3180 例患者中,有 1913 例(60%)再通成功。在这 1913 例患者中,有 1046 例(55%)在 90 天时功能依赖(mRS >2)。mRS 的最重要预测因素是基线患者因素(即,卒中前 mRS,增加 χ 0.16;基线 NIHSS 评分,增加 χ 0.12;年龄,增加 χ 0.10)和术后因素(即,症状性颅内出血(sICH),增加 χ 0.12;肺炎,增加 χ 0.09)。与无 sICH 相比,患有 sICH 的典型卒中患者的功能独立性概率降低了 54%(95%CI 36%至 72%),与无肺炎相比,患有肺炎的患者的功能独立性概率降低了 21%(95%CI 4%至 38%)。
基线患者因素和术后不良事件是缺血性卒中再通成功患者预后不良的重要预测因素。这意味着预防术后不良事件最有可能进一步改善这些患者的结局。